Clinical Trials Logo

Stage II Pancreatic Cancer clinical trials

View clinical trials related to Stage II Pancreatic Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03825289 Recruiting - Clinical trials for Stage IV Pancreatic Cancer

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

THREAD
Start date: January 18, 2019
Phase: Phase 1
Study type: Interventional

This phase I trial studies the sides effects and best dose of hydroxychloroquine when given together with trametinib in treating patients with pancreatic cancer that has spread to nearby tissue, lymph nodes or other places in the body and cannot be removed by surgery. Trametinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as hydroxychloroquine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving trametinib together with hydroxychloroquine may work better in treating patients with pancreatic cancer.